The Increase In Funding For The Genome Editing Is Anticipated To Drive The Genome Editing Market From 2018 to 2025.
Genome editing is a techniques that is used for the changing the DNA of a cell of an organism. The technique involves cutting of DNA sequences for the addition or the removal of the DNA in the genome. The targeted stakeholders for the reports include service providers, vendors, research institutes, supplier, and distributors of genome editing technologies.
The global genome editing market is expected to reach US$ 10,691.0 Mn 2025 from US$ 3,210.1 Mn in 2017. The market is anticipated to grow at a CAGR of 17.0% in the forecasted period.
Get Sample Pages at https://www.theinsightpartners.com/sample/TIPHE100000853
The increase in funding for the genome editing is anticipated to grow in the coming near future which is driving the market. The various different government in the different regions are increasing their funds and grants for the development of the genome editing research. Owing to the advantages of the genome editing various government are supporting their public and private research and academic institutes for the increasing the research activities for the genome editing and genetic engineering. Across the world funding are being provided by the every nation. For instance, in January, 2018 US government announced donating US$ 190 million for research for the next six years. In addition the government is hoping to develop therapies to treat cancer and other diseases using gene editing. In addition, the National Institutes of Health (NIH) has kept approximately US$ 45.5 million separate for the next four fiscal years for Somatic Cell Genome Editing program. Moreover, in the Asia Pacific region, the countries are also investing more for the development of the genome editing technology since two three years back. For instance, in April 2016, Japan invested approximately US$76million for the five years for the creation of Japanese owned genome editing technologies. Likewise, in every region the governments are spending more to conduct the genome editing so as to enhance the development of genome editing for the diagnosis and therapeutic use so as to treat the chronic genetic diseases.
The advantages of the CRISPR technology is found to be the revolutionary technique in the field of the biotechnology and it used for every procedure of the genome editing. The companies are engaged in the developing the techniques for its applications. For instance, Merck KGaA is multinational pharmaceutical, chemical and Life Sciences Company operating in business segments including healthcare, life science and performance material. In April, 2018, the company has received patent for CRISPR technology which used in genomic-integration method for eukaryotic cells. The patent was given by Chinese Patent Office. In addition, in February 2018, The Korean Intellectual Property Office and the Israel Patent Office granted individual patents to Merck for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells. Furthermore, in May, 2018, the company has collaborated with the Washington University in St. Louis, Missouri, USA, which led to the optimizing of nutritional supplements to restore a healthy gut microbial community (microbiome). The collaboration have utilized the CRISPR genome-editing technology for the research studies. Thus, the increase in the developments for the genome editing is likely to growth the market of genome editing in the coming forecast years.
The market in different regions is analyzed by the PEST analysis and the SWOT analysis is provided for the profiled companies in our scope of study. For instance, the PEST analysis of the North America region contain political factor – changes in the regulation for the crops, the economic factor – funding for the genome editing, social factor – acceptance of the genome editing, and the technological factor – developments for CRISPR. Thus, the report provides all the major factors, such as drivers, restraints, opportunities, trends that are impacting the growth of the genome editing in the forecasted period.
The prominent players operating in the market include Transposagen Biopharmaceuticals, Inc., Integrated DNA Technologies, Inc., Thermo Fisher Scientific Inc., GenScript, Lonza, Horizon Discovery Group plc, Sangamo Therapeutics, Inc., New England Biolabs, Editas Medicine and Merck KGaA.
Browse Complete Report at https://www.theinsightpartners.com/reports/genome-editing-market
TABLE OF CONTENTS
1. INTRODUCTION 22
1.1 SCOPE OF THE STUDY 22
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 22
2. GLOBAL GENOME EDITING MARKET – KEY TAKEAWAYS 23
3. GLOBAL GENOME EDITING MARKET – MARKET LANDSCAPE 26
3.1 OVERVIEW 26
3.2 MARKET SEGMENTATION 26
3.2.1 Global Genome Editing Market – By Technology 27
3.2.2 Global Genome Editing Market – By Application 27
3.2.3 Global Genome Editing Market – By End User 28
3.2.4 Global Genome Editing Market – By Geography 28
3.3 PEST ANALYSIS 29
3.3.1 North America – PEST Analysis 29
3.3.2 Europe– PEST Analysis 31
3.3.3 Asia Pacific – PEST Analysis 33
3.3.4 Middle East And Africa– PEST Analysis 35
3.3.5 South and Central America – PEST Analysis 37
4. GLOBAL GENOME EDITING MARKET – KEY MARKET DYNAMICS 39
4.1 KEY MARKET DRIVERS 39
4.1.1 Increase in funding for the genome editing 39
4.1.2 Rising prevalence of the genetic diseases 39
4.1.3 Rise in the advancements for genome editing technologies 40
4.1.4 Rise in the production of genetically modified crops 41
4.2 KEY MARKET RESTRAINTS 41
4.2.1 Perception of the people for genetic alteration 41
4.2.2 Stringent regulations 42
4.3 KEY MARKET OPPORTUNITIES 42
4.3.1 Emerging markets for precision and regenerative medicines 42
4.4 FUTURE TRENDS 43
4.4.1 Usage of CRISPR Cas9 technology 43
4.5 IMPACT ANALYSIS 44
5. GENOME EDITING MARKET – GLOBAL ANALYSIS 45
5.1 GLOBAL GENOME EDITING MARKET REVENUE FORECASTS AND ANALYSIS 45
5.2 GLOBAL GENOME EDITING MARKET, BY GEOGRAPHY – FORECASTS AND ANALYSIS 46
5.3 MARKET POSITIONING 46
5.4 PERFORMANCE OF KEY PLAYERS 47
5.4.1 Thermo Fisher Scientific Inc. 47
5.4.2 Merck KGaA 47
5.4.3 GenScript 47
5.5 EXPERT OPINIONS 48
Get Free 20% Customization with the Purchase at https://www.theinsightpartners.com/buy/TIPHE100000853
Contact us –
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : firstname.lastname@example.org
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.